Associate Professor, Medicine-Massachusetts General Hospital, Harvard Medical School
Oncology
Dr. Sridhar Ramaswamy, MD
|
|
Give Review
Sridhar Ramaswamy is an expert in the field of Oncology. He researched medicine at Boston University School of Medicine. Boston University School of Medicine is ranked 30/52 in Research/PrimaryCare. He has 1 awards "Elected Member". Dr. Sridhar Ramaswamy is a published doctor and has 31 publications published. The lastest was: 'Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer.'
Publications
- Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer.
- Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer.
- A mechanism for asymmetric cell division resulting in proliferative asynchronicity.
- MAPK7 regulates EMT Features and Modulates the Generation of CTCs.
- Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models.
- Patient-derived models of acquired resistance can identify effective drug combinations for cancer.
- Small molecules facilitate rapid and synchronous iPSC generation.
- Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells.
- Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.
- Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.
- Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.
- Targeting transcription regulation in cancer with a covalent CDK7 inhibitor.
- Distinct, strict requirements for Gfi-1b in adult bone marrow red cell and platelet generation.
- Isolation and Molecular Characterization of Circulating Melanoma Cells.
- Dynamic Chromatin Modification Sustains Epithelial-Mesenchymal Transition following Inducible Expression of Snail-1.
- mTOR Inhibition Specifically Sensitizes Colorectal Cancers with KRAS or BRAF Mutations to BCL-2/BCL-XL Inhibition by Suppressing MCL-1.
- The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis.
- Cross-species array comparative genomic hybridization identifies novel oncogenic events in zebrafish and human embryonal rhabdomyosarcoma.
- Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detection.
- Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.
- A molecular roadmap of reprogramming somatic cells into iPS cells.
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.
- Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer.
- RBF binding to both canonical E2F targets and non-canonical targets depends on functional dE2F/dDP complexes.
- The Polycomb Group Protein L3mbtl2 Assembles an Atypical PRC1-Family Complex that Is Essential in Pluripotent Stem Cells and Early Development.
- RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis.
- Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequency.
- Nodes-and-connections RNAi knockdown screening: identification of a signaling molecule network involved in fulvestrant action and breast cancer prognosis.
- RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer.
- SIRT6 Is Required for Normal Retinal Function.
Schools
Boston University School Of Medicine
Columbia Presby Med Center
Dana Farber Cancer InstHarvard Med School
Doctors Specialties
- Internal Medicine
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- GHI PPO
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Elected Member
Education
-
Brigham and Women's Hospital -
New York Presbyterian Hospital - Columbia Campus -
Boston University School of Medicine
Hospital
-
Massachusetts General Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Lori J. Wirth, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lauren C. Harshman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy S. Abramson, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jorge E. Casal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joanne M. Murabito, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Warren Hershman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wambui Chege, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gretchen A. Gignac, MD
This Doctor is OpenDoctor Recommended.
|